Biotech Wednesday with HollandBIO: Guiding Cancer Treatments in the 21st Century - Joining forces to outsmart cancer
New date! Join us for the second joint Oncode-Holland Bio event on guiding cancer treatments in the 21st century.
We are slowly moving away from the ‘one biomarker: one drug’ scenario, which has characterized the first decades of targeted cancer drug development, toward a more integrated approach with multiple biomarkers and drugs. This ‘new paradigm’ will likely pave the way for the introduction of multiplexing strategies in the clinic using companion diagnostics and patient stratification methodologies. We will cover the frontering developments from early stage to and clinical studies, clinically validated diagnostics, biomarkers, genomics, and other molecular approaches that are now an indispensable part of 21st century’s cancer treatment.
The goal of the second Biotech Wednesday is to bring together researchers, clinicians and industry that are developing and utilizing next generation diagnostics for precision medicine, from early to the marketed stages, so you can connect and learn from each other.
We will focus on questions such as What are the current state-of art technologies? What are the key processes and indicators of true clinical utility and impact? How to bring such methods and technologies from the lab to enable decision making for patient care?
- Date: 25 November, 2020
- Time: 12.00 - 18.00
- Location: Pakhuis de Zwijger, Amsterdam
The programme will be announced soon.
If you would like to join us for this event, you can register at the HollandBio website.